European Heart Journal Advance Access originally published online on April 8, 2005
European Heart Journal 2005 26(16):1660-1665; doi:10.1093/eurheartj/ehi198
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
1Department of Thoracic and Cardiovascular Surgery, Rikshospitalet University Hospital, N-0027 Oslo, Norway
2Research Institute for Internal Medicine, Rikshospitalet University Hospital, N-0027 Oslo, Norway
3Department of Cardiology, Rikshospitalet University Hospital, N-0027 Oslo, Norway
4Department of Pathology, Rikshospitalet University Hospital, N-0027 Oslo, Norway
5Department of Clinical Chemistry, Rikshospitalet University Hospital, N-0027 Oslo, Norway
6Section of Clinical Immunology and Infection Diseases, Medical Department, Rikshospitalet University Hospital, N-0027 Oslo, Norway
7Institute of Immunology, Rikshospitalet University Hospital, N-0027 Oslo, Norway
Received 30 April 2004; revised 31 January 2005; accepted 3 February 2005; online publish-ahead-of-print 8 April 2005.
* Corresponding author. Tel: +47 90630015; fax: +47 23073510. E-mail address: t.e.mollnes{at}labmed.uio.no
Aims Transplant-associated coronary artery disease (TxCAD) is a major cause of post-transplant graft failure. The aim of this study was to investigate a possible role of mannose-binding lectin (MBL) deficiency and complement activation in TxCAD.
Methods and results In a prospective study of heart transplant recipients (n=38) with a follow-up of 5.3±1.3 years (range: 0.96.6), angiographically verified TxCAD (n=6) was correlated to plasma MBL, complement activation, and endothelial activation (soluble E-selectin). MBL deficiency (<100 ng/mL) was detected in 3/6 patients with TxCAD and in 3/32 with non-TxCAD (KaplanMeier, P=0.020). Furthermore, one or more acute rejection episodes were observed in 6/6 of the MBL-deficient patients and in 15/32 of the MBL-sufficient patients (
2; P=0.016). Complement activation (C4bc) correlated with soluble E-selectin (r=0.36; P=0.027), both being significantly higher in patients with ischaemia detected in the first biopsy (C4bc: 13.4±6.1 AU/mL; E-selectin: 96±13 ng/mL) than in those without ischaemia (C4bc: 6.3±0.5; E-selectin: 51±6; P=0.037 and 0.002). Finally, terminal complement complex correlated closely with mortality (P=0.002).
Conclusion Low MBL was related to the development of TxCAD and acute rejection and increased complement activation correlated to histopathologic ischaemia and mortality after heart transplantation.
Key Words: Transplant-associated coronary artery disease Ischaemia-reperfusion Graft rejection Complement Mannose-binding lectin Soluble E-selectin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Hjelmesaeth, T. Ueland, A. Flyvbjerg, J. Bollerslev, T. Leivestad, T. Jenssen, T. K. Hansen, S. Thiel, S. Sagedal, J. Roislien, et al. Early Posttransplant Serum Osteoprotegerin Levels Predict Long-Term (8-Year) Patient Survival and Cardiovascular Death in Renal Transplant Patients J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1746 - 1754. [Abstract] [Full Text] [PDF] |
||||
